Human isotope fractional absorption studies comparing chelated Magnesium Glycinate vs. Citrate vs. 4% Oxide, CYP2R1/CYP27B1 magnesium-dependent Vitamin D3 activation trials, and Metformin-induced Vitamin B12 holotranscobalamin depletion. Explore 4,327 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
The DAS is a reliable measure of 5 delusional domains.
Aside from adverse effects of venlafaxine XR on sexual function, both treatments were reasonably well tolerated.
All treatments led to a reduction in depression, but the advantages of a combined approach were not evident.
Treatment with rosuvastatin and atorvastatin produced beneficial lipid changes in this group of Hispanic patients that appear comparable in magnitude to those observed in.
Diastolic function improved significantly in group L (P<.05).
Bright light did not have a sustained effect after discontinuation.
Stimulation of the central monoaminergic system with the antidepressants bupropion and sertraline did not enhance the retrieval of long-term emotional memories in man.
The results of this study suggest that sildenafil citrate treatment for ED in PTSD patients was accompanied with improvement of ED symptoms and was found to be significantly better than placebo.
Trouble sleeping was the most important factor compromising the success of OSAS treatment with IOMRAs, and the isolated presence of gastric, neurological and rheumatic diseases, but especially their combination, reduces the...
Despite the absence of motor complications, the pramipexole recipients showed improvement on the Unified Parkinson's Disease Rating Scale (UPDRS) motor subscore.
Combined sleep hygiene and melatonin was a safe and effective treatment for initial trouble sleeping in children with ADHD taking stimulant medication.
This study showed a comparable reduction in blood pressure with both blood-pressure-lowering drugs.
The early use of estrogen improves endometrial tissue and requires lower daily dosage.
Treatment with CC is associated with higher rates of pregnancy if started early (days 1-5) in the menstrual cycle.
No significant change in GFR from baseline after 16 weeks was observed for either treatment group.
Our results show that the administration of losartan, but not amlodipine, to hypertensive patients improves structural abnormalities and prevents the production of CTGF and TGF-beta in small arteries, despite similar BP lowering.
After unsuccessful treatment with an SSRI, approximately one in four patients had a full symptom relief of symptoms after switching to another antidepressant.
Augmentation of citalopram with either sustained-release bupropion or buspirone appears to be useful in actual clinical settings.
According to the Sex FX scale, a significant difference in antidepressant-related sexual dysfunction was detected in men, but not women, during treatment with bupropion SR or paroxetine.
The use of losartan in combination with amiodarone seems more effective than amlodipine/amiodarone combination in preventing new episodes of irregular heartbeat (AFib) in hypertensive patients with recurrent irregular...
ARB blood-pressure-lowering therapy may have a uniquely beneficial metabolic effect in addition to blood pressure lowering.
No statistically significant differences were found comparing the hormonal profile dynamics, the mid-luteal (HCG day +8) oestradiol/progesterone ratio and the percentage of mid-luteal oestradiol decline between the study and...
Adapalene gel 0.1% has tolerability superior to both tazarotene cream 0.05% and tretinoin microsphere 0.04% when used in applied to the skin combination therapy.
The 2 study medications were well tolerated during the 6-week study period.
Compared to those without SUD, MDD patients with concurrent SUD were more likely to be younger, male, divorced or never married, and at greater current suicide risk, and have an earlier age of onset of depression, greater...
At equivalent doses, rosuvastatin had a significantly greater effect than atorvastatin in lowering LDL-C and improving the lipid profile and was well tolerated in patients with the metabolic syndrome.
Similarly, a transient decline in E2 levels does not effectively restore normal pituitary ovarian feedback.
The hypothesis that CBT would improve daytime functioning more than SMW was only supported by a global rating measure.
These findings support the efficacy of rTMS in hastening the response to antidepressant drugs in patients with depression.
Caregiver depression and burden affect their rating of AD patients' mood, but the majority of variance is due to patient characteristics.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
